Terms: = Kidney tumors AND FLCN, BHD, 201163, ENSG00000154803, MGC23445, MGC17998, FLCL AND Prognosis
7 results:
1. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract] [Full Text] [Related]
2. Genotype-phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions.
Zhang K; Yang W; Ma K; Qiu J; Li L; Xu Y; Zhang Z; Yu C; Zhou J; Gong Y; Cai L; Gong K
J Med Genet; 2023 May; 60(5):477-483. PubMed ID: 37080588
[TBL] [Abstract] [Full Text] [Related]
3. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
4. Birt-Hogg-Dubé syndrome with simultaneous hyperplastic polyposis of the gastrointestinal tract: case report and review of the literature.
Balsamo F; Cardoso PAS; do Amaral Junior SA; Theodoro TR; de Sousa Gehrke F; da Silva Pinhal MA; Bianco B; Waisberg J
BMC Med Genet; 2020 Mar; 21(1):52. PubMed ID: 32171268
[TBL] [Abstract] [Full Text] [Related]
5. Oncotargets in different renal cancer subtypes.
Moch H; Montironi R; Lopez-Beltran A; Cheng L; Mischo A
Curr Drug Targets; 2015; 16(2):125-35. PubMed ID: 25619751
[TBL] [Abstract] [Full Text] [Related]
6. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Schmidt LS
Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
[TBL] [Abstract] [Full Text] [Related]
7. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract] [Full Text] [Related]